Resources

According to Jenise Wong, MD, PhD, of the University of California San Francisco, who reported the results at an oral session at the joint meeting of the Endocrine Society and the International Congress on Endocrinology, “We need to really equip patients with better tools and education on how to use their data.” David Kliff responds: Now some would argue that this is why IDM is needed, as it not only collects and transmits data, but it provides for an easy interaction between the patient and their healthcare team; that it’s the healthcare team that’s doing all the data analytics; that all the patient needs to do is collect the data; and that this focus on data can actually make a patient tune out even when they are getting good advice. Here is a perfect example of what we are talking about. Read more

Study suggests extreme calorie reduction may have same effect as bariatric surgery.

In this week's Homerun Slides, the philosophy for the reduced need for insulin in type 2 patients and the potential benefits of combining GLP-1-based therapies with insulin.

Male, 72 years of age, type 2, insulin requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of work day, glucose elevated much higher than he reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy, leukocyte esterase 2+, wbc >60 H, bacteria many (>50) H, RBC 3-10, H.

A critical requirement for orderly epidemiologic, genetic and clinical research, and indeed for the management of diabetes mellitus and other forms of glucose intolerance is an appropriate classification system. Furthermore, a hallmark in the process of understanding the etiology of a disease and studying its natural history is the ability to identify and differentiate its various forms and place them into a rational etiopathologic framework.

Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association's 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.

Diet containing foods high in antioxidants found to reduce risk of stroke.

Longer duration of breastfeeding showed correlation with reduction of type 2 risk.

Treatment improves insulin sensitivity, lowers risk of heart and kidney disease.

Evidence shows cardio-protective ability beyond glucose-lowering mechanism of action.